These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30880980)

  • 1. Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.
    Jiang H; Li ZP; Tian GX; Pan RY; Xu CM; Zhang B; Wu JL
    Int J Nanomedicine; 2019; 14():1789-1804. PubMed ID: 30880980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
    Lian B; Wei H; Pan R; Sun J; Zhang B; Wu J; Li X; Tian G
    Int J Nanomedicine; 2021; 16():457-467. PubMed ID: 33488080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
    Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
    Wang WY; Cao YX; Zhou X; Wei B
    Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.
    Wang F; Li Y; Jiang H; Li C; Li Z; Qi C; Li Z; Gao Z; Zhang B; Wu J
    Int J Nanomedicine; 2021; 16():4001-4016. PubMed ID: 34135585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.
    Ma Q; Qian W; Tao W; Zhou Y; Xue B
    Drug Des Devel Ther; 2019; 13():4021-4033. PubMed ID: 31819373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of curcumin by functional solid lipid nanoparticles with promoting endosomal escape and liver targeting properties.
    Zhang M; Liang J; Liang Y; Li X; Wu W
    Colloids Surf B Biointerfaces; 2024 Dec; 244():114177. PubMed ID: 39217729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting.
    Yang C; Chen H; Zhao J; Pang X; Xi Y; Zhai G
    Colloids Surf B Biointerfaces; 2014 Sep; 121():206-13. PubMed ID: 24984268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
    Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
    Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.
    Zhang Y; Zhou J; Yang C; Wang W; Chu L; Huang F; Liu Q; Deng L; Kong D; Liu J; Liu J
    Int J Nanomedicine; 2016; 11():1119-30. PubMed ID: 27051287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis.
    Qi C; Wang D; Gong X; Zhou Q; Yue X; Li C; Li Z; Tian G; Zhang B; Wang Q; Wei X; Wu J
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16019-16035. PubMed ID: 33819006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded redox response of self-assembled micelles for enhanced antitumor and anti-inflammation efficacy.
    Zhao S; Ma L; Cao C; Yu Q; Chen L; Liu J
    Int J Nanomedicine; 2017; 12():2489-2504. PubMed ID: 28408820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and
    Li W; Xiong X; Gong Y; Li Z
    Curr Drug Deliv; 2024; 21(4):592-602. PubMed ID: 37340749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.